Hydrazine → HCID 178448312, compound

HRID 1016112Notes

Reaction equation

HRID 1016112 reaction equation
[C:1](/[N:9]=[C:10](\SC)/[NH:11][C@H:12]([CH:28]([CH3:30])[CH3:29])[C:13]([N:15]1[CH2:20][CH2:19][CH:18]([C:21]2[CH:26]=[CH:25][C:24]([Cl:27])=[CH:23][CH:22]=2)[CH2:17][CH2:16]1)=[O:14])(=O)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[NH2:33][NH2:34]>C1COCC1>[Cl:27][C:24]1[CH:25]=[CH:26][C:21]([CH:18]2[CH2:19][CH2:20][N:15]([C:13](=[O:14])[C@H:12]([NH:11][C:10]3[NH:34][N:33]=[C:1]([C:2]4[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=4)[N:9]=3)[CH:28]([CH3:30])[CH3:29])[CH2:16][CH2:17]2)=[CH:22][CH:23]=1

Participants

4

Procedure

(R,Z)-Methyl N′-benzoyl-N-(1-(4-(4-chlorophenyl)piperidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamimidothioate (47 mg, 0.1 mmol) was dissolved in THF (0.5 mL) and treated with anhydrous hydrazine (10 μL, 0.3 mmol). The reaction was stirred at rt. overnight. After this time, the THF was removed in vacuo and the resulting residue was dissolved in methanol and then purified by preparative HPLC to give (R)-1-(4-(4-chlorophenyl)piperidin-1-yl)-3-methyl-2-(3-phenyl-1H-1,2,4-triazol-5-ylamino)butan-1-one (20 mg, 45%). MS found: 438 (M+H).

Workup

  1. customovernight
  2. customAfter this time, the THF was removed in vacuo
  3. dissolutionthe resulting residue was dissolved in methanol
  4. custompurified by preparative HPLC

Sources & evidence

ORD record
ord-d55387159388491aa5f42841dc3d3777
Source dataset
uspto-grants-2011_07
Patent number
US07985861B2

Reaction notes

Loading…